NEW YORK ( TheStreet) -- Shares of Cardiome Pharma Corp (Nasdaq: CRME) were gapping up Tuesday morning with an open price 12% higher than Monday's closing price. The stock closed at $4.34 Monday and opened today's trading at $4.86. The average volume for Cardiome has been 234,900 shares per day over the past 30 days. Cardiome has a market cap of $265.9 million and is part of the health care sector and drugs industry. Shares are down 32.4% year to date as of the close of trading on Monday. Cardiome Pharma Corp., a life sciences company, engages in developing proprietary drugs to treat or prevent cardiovascular and other diseases. The company has a P/E ratio of 21.8, equal to the average drugs industry P/E ratio and above the S&P 500 P/E ratio of 17.7. TheStreet Ratings rates Cardiome as a hold. The company's strengths can be seen in multiple areas, such as its good cash flow from operations, largely solid financial position with reasonable debt levels by most measures and notable return on equity. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself and deteriorating net income. You can view the full Cardiome Ratings Report. Get more investment ideas from our investment research center. Interested in other stocks that are gapping up? Get free SMS text alerts sent to you when the action happens by texting UP to 95370 or select from multiple alert options.
More from Markets
You Can Buy Some FAANG Stocks Here, But Don't 'Load Up' on Them, Jim Cramer Says
'If you just own FAANG names, that's not very diversified,' he says.
Starbucks Is Now a Turnaround Story -- Here's How Management Did It
Let's just say third quarter didn't disappoint. Read ICYMI to find out what that really means.
Ask Cramer: Book Recommendations for College Grads Starting Their First Job?
Which of Jim Cramer's books does he recommend for grandchildren out of college on their first job?